Brokerages Set Varex Imaging (NASDAQ:VREX) Target Price at $16.17

Varex Imaging (NASDAQ:VREX) has received a consensus recommendation of “Moderate Buy” from the five analysts that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, two have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $16.1667.

Several equities analysts have recently weighed in on VREX shares. Jefferies Financial Group reiterated a “hold” rating and issued a $14.50 target price on shares of Varex Imaging in a research note on Monday, February 2nd. Zacks Research upgraded shares of Varex Imaging from a “hold” rating to a “strong-buy” rating in a research note on Monday, April 13th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Varex Imaging in a report on Friday, March 27th. Wall Street Zen upgraded shares of Varex Imaging from a “buy” rating to a “strong-buy” rating in a research note on Saturday, February 28th. Finally, B. Riley Financial reissued a “buy” rating on shares of Varex Imaging in a report on Thursday, February 12th.

Varex Imaging Stock Up 0.3%

VREX stock opened at $12.00 on Wednesday. The stock has a fifty day moving average of $11.86 and a 200-day moving average of $12.14. Varex Imaging has a fifty-two week low of $6.76 and a fifty-two week high of $14.56. The company has a market capitalization of $502.80 million, a price-to-earnings ratio of -7.32 and a beta of 0.99. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.87 and a current ratio of 3.89.

Varex Imaging (NASDAQ:VREX) last announced its quarterly earnings data on Tuesday, February 10th. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.14 by $0.05. The business had revenue of $209.60 million for the quarter, compared to analysts’ expectations of $207.83 million. Varex Imaging had a positive return on equity of 8.43% and a negative net margin of 7.92%.Varex Imaging has set its Q2 2026 guidance at 0.150-0.250 EPS. As a group, equities research analysts predict that Varex Imaging will post 0.93 earnings per share for the current year.

Insider Buying and Selling at Varex Imaging

In other news, Director Jay K. Kunkel sold 4,510 shares of Varex Imaging stock in a transaction on Friday, March 20th. The stock was sold at an average price of $11.14, for a total value of $50,241.40. Following the completion of the transaction, the director directly owned 23,450 shares in the company, valued at approximately $261,233. The trade was a 16.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 4.60% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. State of Alaska Department of Revenue purchased a new position in Varex Imaging during the 3rd quarter valued at about $27,000. Rockefeller Capital Management L.P. purchased a new stake in shares of Varex Imaging in the fourth quarter worth about $27,000. Quarry LP bought a new position in shares of Varex Imaging in the third quarter valued at approximately $64,000. BNP Paribas Financial Markets boosted its position in shares of Varex Imaging by 18.5% in the second quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock valued at $113,000 after acquiring an additional 2,036 shares during the period. Finally, Aquatic Capital Management LLC purchased a new position in Varex Imaging during the third quarter valued at approximately $117,000.

About Varex Imaging

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.